- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03428776
Timeliness of Immunization and Compliance Assessment Study (TICA)
September 25, 2019 updated by: Johns Hopkins University
Although coverage for primary childhood immunizations has improved, a significant proportion of young children and pregnant women living in low-resource settings remain inadequately immunized.
While young children receive some primary vaccines, many are never fully vaccinated.
Progressive decline in immunizations are in large part attributable to poor follow-up and compliance.
Major challenges include maintaining immunization records linked to positive identification of the individual child, incentivizing follow-up and return immunizations and efficiently identifying and targeting non-compliant subjects.
Mobile-phone costs have decreased dramatically in the developing world with rapid proliferation of web and mobile-phone connectivity.
Novel approaches that integrate these modern technologies with existing resources in low and middle income countries can cost-effectively address these challenges.
In this proposal, investigators will evaluate a novel software platform, utilizing biometric identification and of subjects, paired with intelligent and subject-aware, mobile-phone reminders and compliance-linked incentives to improve uptake and coverage of primary vaccinations in young children.
Study Overview
Status
Completed
Conditions
Detailed Description
A cloud-based, biometric-linked vaccination record, mobile-phone reminder and compliance-linked incentive software platform to provide robust and universal access of vaccinations.
The investigators will implement this platform in a low-resource settings with the following features: a) Cloud-based for robust and universal access.
b) Biometric-linked for positive identification.
c) Digital storage and reporting for transparent view of program operations.
d) Global Positioning System (GPS)-linked, allowing rapid assessment of vaccination status of communities.
e) Increasing vaccination uptake and coverage by intelligent and subject-aware automated reminders and compliance-linked incentives.
Study Type
Interventional
Enrollment (Actual)
2065
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haryana, India, 21287
- BUDS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 2 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Mother (or caregiver) with one or more children ≤24 months in their family will be enrolled
- There will be no exclusion criteria based on race, ethnicity or gender.
Exclusion Criteria:
- Participants unable or unwilling to comply with the protocol or with any other condition that would impede compliance or hinder completion of the study (e.g. no mobile-phone in the family), or failure to give informed consent would be the only exclusion criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Controls
Self returns
|
Electronic immunization records on cloud-based software platform and use of biometric identification
|
Active Comparator: Standard Compliance-linked incentives
Standard mobile-phone reminders and compliance-linked incentives
|
Standard mobile-phone reminders and compliance-linked incentives Electronic immunization records on cloud-based software platform and use of biometric identification
|
Active Comparator: Intelligent Compliance-linked incentives
Intelligent mobile-phone reminders and compliance-linked incentives
|
Intelligent mobile-phone reminders and compliance-linked incentives Electronic immunization records on cloud-based software platform and use of biometric identification
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Timeliness of immunization
Time Frame: 12-15 months
|
Defined as the proportion of immunizations administered before the scheduled date or within 14 days of the after scheduled date.
|
12-15 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Immunization rate
Time Frame: 12-15 months
|
Calculated for each individual child and defined as the proportion of the total number of immunizations received divided by the total number of immunizations required at the time of measurement (e.g. at enrollment, end of study, etc.).
|
12-15 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 25, 2018
Primary Completion (Actual)
September 25, 2019
Study Completion (Actual)
September 25, 2019
Study Registration Dates
First Submitted
February 5, 2018
First Submitted That Met QC Criteria
February 5, 2018
First Posted (Actual)
February 12, 2018
Study Record Updates
Last Update Posted (Actual)
September 27, 2019
Last Update Submitted That Met QC Criteria
September 25, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- IRB00161339
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccinations
-
M.D. Anderson Cancer CenterActive, not recruitingVaccinationsUnited States
-
Emory UniversityCompleted
-
University of California, DavisCompletedHPV VaccinationsUnited States
-
University of PittsburghBaylor College of Medicine; Centers for Disease Control and PreventionCompletedAdult Influenza Vaccinations | Adult PPSV Vaccinations | Adult Tdap/Td VaccinationsUnited States
-
University of North Carolina, Chapel HillMerck Sharp & Dohme LLCCompletedEvaluating Attitudes Toward HPV Vaccinations in Pharmacies | Evaluating the Provision of HPV Vaccines in a PharmacyUnited States
-
University Hospital, Strasbourg, FranceCompletedHIV Infection | Sexually Transmitted Diseases | Vaccinations | Prep PrescriptionFrance
-
Wake Forest University Health SciencesRecruiting
Clinical Trials on Record keeping
-
Ankara City Hospital BilkentCompleted
-
National Society for the Prevention of Cruelty...Department of Education Northern IrelandCompletedEvaluating the Effectiveness of Keeping Safe - a School Based Intervention Aimed at Preventing AbuseChild MaltreatmentUnited Kingdom
-
University of MichiganCompletedUrinary Incontinence | Pelvic Organ Prolapse | Perinatal Laceration | Second Stage LaborUnited States
-
Medical University of ViennaRecruitingEndovenous Laser Ablation | Great Saphenous Vein IncompetenceAustria
-
Hektoen Institute for Medical ResearchNational Institutes of Health (NIH)RecruitingHIV Infections | Sexual BehaviorUnited States
-
University of MichiganCompletedUrinary Incontinence | Bladder ControlUnited States
-
Necmettin Erbakan UniversityCompletedMental Health | Antenatal CareTurkey
-
University of NottinghamNational Institute for Health Research, United KingdomCompletedPhysical Activity | Falls Prevention
-
Oregon Center for Applied Science, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Corporacion Parc TauliCompleted